Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Altered cardiac excitability and arrhythmia in models of SCN1B-linked developmental and epileptic encephalopathy
Roberto Ramos-Mondragon, Shuyun Wang, Nnamdi Edokobi, Qinghua Liu, Xiaotan Qiao, Maya Shih, Louis T. Dang, Yao-Chang Tsan, Katalin Štěrbová, Adam S. Helms, Sarah Weckhuysen, Luis F. Lopez-Santiago, Jack M. Parent, Lori L. Isom
Roberto Ramos-Mondragon, Shuyun Wang, Nnamdi Edokobi, Qinghua Liu, Xiaotan Qiao, Maya Shih, Louis T. Dang, Yao-Chang Tsan, Katalin Štěrbová, Adam S. Helms, Sarah Weckhuysen, Luis F. Lopez-Santiago, Jack M. Parent, Lori L. Isom
View: Text | PDF
Research Article Cardiology Stem cells

Altered cardiac excitability and arrhythmia in models of SCN1B-linked developmental and epileptic encephalopathy

  • Text
  • PDF
Abstract

Biallelic variants in SCN1B, which encodes the voltage-gated sodium channel β1/β1B subunits, are linked to DEE52, a developmental and epileptic encephalopathy with a high risk of sudden unexpected death in epilepsy (SUDEP). DEE52 patients present clinically with Dravet syndrome or the more severe early infantile DEE. SCN1B is expressed in brain and heart in humans and in mice. Thus, we have proposed that, in addition to generalized seizures, cardiac arrhythmia may play a role in SUDEP. Mice with homozygous expression of the DEE52 variant Scn1b-c.265C>T, predicting p.R89C, have spontaneous and hyperthermia-induced generalized seizures and SUDEP. Here we conducted cardiac characterization of Scn1b-c.265C>T mice and studied induced pluripotent stem cell cardiomyocytes (iPSC-CMs) derived from 2 SCN1B-c.265C>T DEE52 patients. Scn1bC89/C89 mouse CMs showed increased transient outward potassium current (Ito) density and heart sections revealed ventricular fibrosis. Scn1bC89/C89 mice were susceptible to pacing-induced cardiac arrhythmias. Patient-derived iPSC-CMs with biallelic SCN1B-c.265C>T variant expression showed increased sodium current (INa), late INa, and Ito current densities. We conclude that, while mouse and human cardiac AP waveforms have critical differences, increased Ito is common to both models of DEE52. Overall, our data suggest that electrical and structural substrates may lead to arrhythmias and contribute to SUDEP in DEE52.

Authors

Roberto Ramos-Mondragon, Shuyun Wang, Nnamdi Edokobi, Qinghua Liu, Xiaotan Qiao, Maya Shih, Louis T. Dang, Yao-Chang Tsan, Katalin Štěrbová, Adam S. Helms, Sarah Weckhuysen, Luis F. Lopez-Santiago, Jack M. Parent, Lori L. Isom

×

Figure 8

Transient and persistent INa are increased in patient iPSC-CMs.

Options: View larger image (or click on image) Download as PowerPoint
Transient and persistent INa are increased in patient iPSC-CMs.
(A) Repr...
(A) Representative INa density traces of SCN1BR89/R89 controls 1 and 2, SCN1BR89/C89 control, SCN1BC89/C89 Patient 1, and SCN1BC89/C89 Patient 2. (B) INa current-voltage relationship for control and patient iPSC-CM lines. (C) Transient peak INa is increased 2-fold in patient 1 and patient 2 vs. control iPSC-CMs. (D) Voltage-dependent activation and inactivation properties. (E) Zoomed traces of INaL showing the current from 50 to 60 ms following the depolarizing pulse. (F) The mean INaL is significantly increased in the patient iPSC-CMs. (G) INaL normalized to the peak current. Data in C, E, and F are presented as mean ± SEM. n = 10 cells from SCN1BR89/R89 control 1, n = 10 cells from SCN1BR89/R89 control 2, n = 15 cells from SCN1BR89/C89 Parent, n = 17 cells from SCN1BC89/C89 Patient 1, and n = 13 cells from SCN1BC89/C89 Patient 2. All cells were derived from at least 3 independent hiPSC differentiation batches. *P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.0001 using a 1-way ANOVA with Tukey’s post hoc comparison test. Dots represent individual cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts